CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 61 filers reported holding CHEMOCENTRYX INC in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $681,000 | +24.3% | 92,004 | +1.4% | 0.00% | 0.0% |
| Q3 2016 | $548,000 | +34.6% | 90,739 | +0.0% | 0.00% | 0.0% |
| Q2 2016 | $407,000 | +63.5% | 90,704 | -9.2% | 0.00% | – |
| Q1 2016 | $249,000 | -68.7% | 99,912 | +1.9% | 0.00% | -100.0% |
| Q4 2015 | $795,000 | +34.3% | 98,094 | +0.2% | 0.00% | 0.0% |
| Q3 2015 | $592,000 | -28.2% | 97,878 | -2.4% | 0.00% | 0.0% |
| Q2 2015 | $825,000 | +20.3% | 100,271 | +10.4% | 0.00% | 0.0% |
| Q1 2015 | $686,000 | +9.8% | 90,807 | -0.7% | 0.00% | 0.0% |
| Q4 2014 | $625,000 | +52.8% | 91,444 | +0.6% | 0.00% | 0.0% |
| Q3 2014 | $409,000 | -20.3% | 90,935 | +3.7% | 0.00% | 0.0% |
| Q2 2014 | $513,000 | +12.3% | 87,702 | +27.3% | 0.00% | 0.0% |
| Q1 2014 | $457,000 | +16.0% | 68,899 | +1.2% | 0.00% | 0.0% |
| Q4 2013 | $394,000 | +3.4% | 68,075 | -0.6% | 0.00% | 0.0% |
| Q3 2013 | $381,000 | -57.0% | 68,508 | +9.3% | 0.00% | -50.0% |
| Q2 2013 | $886,000 | – | 62,652 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |